Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 750860, 8 pages
http://dx.doi.org/10.1155/2014/750860
Research Article

Early Effects of a Hypocaloric, Mediterranean Diet on Laboratory Parameters in Obese Individuals

1Department of Health Sciences, Magna Græcia University of Catanzaro, Viale Europa (Località Germaneto), 88100 Catanzaro, Italy
2Department of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, Viale Europa (Località Germaneto), 88100 Catanzaro, Italy
3Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, Viale Europa (Località Germaneto), 88100 Catanzaro, Italy

Received 18 December 2013; Accepted 19 January 2014; Published 4 March 2014

Academic Editor: Massimiliano M. Corsi Romanelli

Copyright © 2014 Marta Greco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Obesity: preventing and managing the global epidemic,” WHO Technical Report 894, World Health Organization, Geneva. Switzerland, 2000. View at Google Scholar
  2. C. L. Ogden, M. M. Lamb, M. D. Carroll, and K. M. Flegal, “Prevalence of Obesity in the United States, 2009-2010,” NCHS Data Brief, vol. 82, pp. 1–8, 2012. View at Google Scholar
  3. C. L. Ogden, M. D. Carroll, L. R. Curtin, M. M. Lamb, and K. M. Flegal, “Prevalence of high body mass index in US children and adolescents, 2007-2008,” Journal of the American Medical Association, vol. 303, no. 3, pp. 242–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Vasan, M. J. Pencina, M. Cobain, M. S. Freiberg, and R. B. D'Agostino, “Estimated risks for developing obesity in the Framingham Heart Study,” Annals of Internal Medicine, vol. 143, no. 7, pp. 473–I12, 2005. View at Google Scholar · View at Scopus
  5. S. Klein, L. E. Burke, G. A. Bray et al., “Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism,” Circulation, vol. 110, no. 18, pp. 2952–2967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Poirier and R. H. Eckel, “Obesity and cardiovascular disease,” Current Atherosclerosis Reports, vol. 4, no. 6, pp. 448–453, 2002. View at Google Scholar · View at Scopus
  7. P. Zimmet and K. G. M. M. Alberti, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Hossain, B. Kawar, and M. El Nahas, “Obesity and diabetes in the developing world—a growing challenge,” The New England Journal of Medicine, vol. 356, no. 3, pp. 213–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. A. Bray, A Guide to Obesity and the Metabolic Syndrome, CRC Press, 2011.
  10. H. C. Masouka and N. Chalasani, “Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals,” Annals of the New York Academy of Sciences, vol. 1281, pp. 106–122, 2013. View at Publisher · View at Google Scholar
  11. S. D. Hursting and S. M. Dunlap, “Obesity, metabolic dysregulation, and cancer: a growing concern ad an inflammatory (and microenvironmental) issue,” Annals of the New York Academy of Sciences, vol. 1271, pp. 82–87, 2012. View at Publisher · View at Google Scholar
  12. I. Vucenik and J. P. Stains, “Obesity and cancer risk: evidence, mechanisms, and recommendations,” Annals of the New York Academy of Sciences, vol. 1271, pp. 37–43, 2012. View at Google Scholar
  13. T. Gharibeh and R. Mehra, “Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options,” Nature and Science of Sleep, vol. 2, pp. 233–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Berenbaum, F. Eymard, and X. Houard, “Osteoarthritis, inflammation an obesity,” Current Opinion in Rheumatology, vol. 25, pp. 114–118, 2013. View at Publisher · View at Google Scholar
  15. C. S. Farah and C. M. Salome, “Asthma and obesity: a known association but unknown mechanism,” Respirology, vol. 17, no. 3, pp. 412–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Haslam and W. P. T. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Withrow and D. A. Alter, “The economic burden of obesity worldwide: a systematic review of the direct costs of obesity,” Obesity Reviews, vol. 12, no. 2, pp. 131–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. I. McCarthy, “Genomics, type 2 diabetes, and obesity,” The New England Journal of Medicine, vol. 363, no. 24, pp. 2339–2350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-P. Després and I. Lemieux, “Abdominal obesity and metabolic syndrome,” Nature, vol. 444, no. 7121, pp. 881–887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Tchernof and J. P. Després, “Pathophysiology of human visceral obesity: an update,” Physiological Reviews, vol. 93, pp. 359–404, 2013. View at Publisher · View at Google Scholar
  21. G. A. Rosito, R. B. D'Agostino, J. Massaro et al., “Association between obesity and a prothrombotic state: The Framingham Offspring Study,” Journal of Thrombosis and Haemostasis, vol. 91, pp. 638–639, 2004. View at Google Scholar
  22. C. Bachmayer, A. Lammert, T. Hasenberg, and H. P. Hammes, “Healthy obese and post-bariatric patients—metabolic and vascular patterns,” Experimental and Clinical Endocrinology & Diabetes, vol. 121, no. 8, pp. 483–487, 2013. View at Google Scholar
  23. G. A. Bray and D. H. Ryan, “Medical therapy for the patient with obesity,” Circulation, vol. 125, no. 13, pp. 1695–1703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. H. Eckel, “Nonsurgical management of obesity in adults,” The New England Journal of Medicine, vol. 358, no. 18, pp. 1941–1950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Blackburn, “Effect of degreee of weight loss on health benefits,” Obesity Research, vol. 3, supplement 2, pp. 211–216, 1995. View at Google Scholar
  26. D. J. Goldstein, “Beneficial health effects of modest weight loss,” International Journal of Obesity, vol. 16, no. 6, pp. 397–415, 1992. View at Google Scholar · View at Scopus
  27. I. Shai, D. Schwarzfuchs, Y. Henkin et al., “Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet,” The New England Journal of Medicine, vol. 359, no. 3, pp. 229–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Hainer, H. Toplak, and A. Mitrakou, “Treatment modalities of obesity: what fits whom?” Diabetes Care, vol. 31, no. 2, pp. S269–S277, 2008. View at Google Scholar · View at Scopus
  30. E. Heggen, T. O. Klemsdal, F. Haugen, I. Holme, and S. Tonstad, “Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations,” Metabolic Syndrome and Related Disorders, vol. 10, no. 6, pp. 437–442, 2012. View at Publisher · View at Google Scholar
  31. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. C. Fernandez, A. V. Casariego, I. C. Rodreguez, and M. D. B. Pomar, “One-year effectiveness of two hypocaloric diets with different protein/carbohydrate ratios in weight loss and insulin resistance,” Nutricion Hospitalaria, vol. 27, no. 6, pp. 2093–2101, 2012. View at Google Scholar
  35. L. Stern, N. Iqbal, P. Seshadri et al., “The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial,” Annals of Internal Medicine, vol. 140, no. 10, pp. 778–785, 2004. View at Google Scholar · View at Scopus
  36. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. K. A. Varady, L. Tussing, S. Bhutani, and C. L. Braunschweig, “Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women,” Metabolism: Clinical and Experimental, vol. 58, no. 8, pp. 1096–1101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Deng and P. E. Scherer, “Adipokines as novel biomarkers and regulators of the metabolic syndrome,” Annals of the New York Academy of Sciences, vol. 1212, pp. E1–E19, 2010. View at Google Scholar · View at Scopus
  39. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Galic, J. S. Oakhill, and G. R. Steinberg, “Adipose tissue as an endocrine organ,” Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 129–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Rea and R. Donnelly, “Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity,” Diabetes, Obesity and Metabolism, vol. 6, no. 3, pp. 163–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Wauman and J. Tavernier, “Leptin receptor signaling: pathways to leptin resistance,” Frontiers in Bioscience, vol. 16, no. 7, pp. 2771–2793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. C. Villanueva and M. G. Myers Jr., “Leptin receptor signaling and the regulation of mammalian physiology,” International Journal of Obesity, vol. 32, no. 7, pp. S8–S12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Jéquier, “Leptin signaling, adiposity, and energy balance,” Annals of the New York Academy of Sciences, vol. 967, pp. 379–388, 2002. View at Google Scholar · View at Scopus
  46. J. R. Vasselli, P. J. Scarpace, R. B. Harris, and W. A. Banks, “Dietary components in the development of leptin resistance,” Advances in Nutrition, vol. 4, no. 2, pp. 164–175, 2013. View at Publisher · View at Google Scholar
  47. S. Dagogo-Jack, C. Fanelli, D. Paramore, J. Brothers, and M. Landt, “Plasma leptin and insulin relationships in obese and nonobese humans,” Diabetes, vol. 45, no. 5, pp. 695–698, 1996. View at Google Scholar · View at Scopus
  48. M. W. Schwartz, R. L. Prigeon, S. E. Kahn et al., “Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms,” Diabetes Care, vol. 20, no. 9, pp. 1476–1481, 1997. View at Google Scholar · View at Scopus
  49. K. Anderlová, J. Křemen, R. Doležalová et al., “The influence of very-low-calorie diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women,” Physiological Research, vol. 55, no. 3, pp. 277–283, 2006. View at Google Scholar · View at Scopus
  50. G. Mazzali, V. Di Francesco, E. Zoico et al., “Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: Effect of moderate weight loss in older women,” The American Journal of Clinical Nutrition, vol. 84, no. 5, pp. 1193–1199, 2006. View at Google Scholar · View at Scopus
  51. E. Klimcakova, M. Kovacikova, V. Stich, and D. Langin, “Adipokines and dietary interventions in human obesity,” Obesity Reviews, vol. 11, no. 6, pp. 446–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. C. Klempel and K. A. Varady, “Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans,” Nutrition Reviews, vol. 69, no. 3, pp. 145–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Berrington de Gonzalez, P. Hartge, J. R. Cerhan et al., “Body-mass index and mortality among 1. 46 million white adults,” The New England Journal of Medicine, vol. 363, pp. 2211–2219, 2010. View at Publisher · View at Google Scholar
  54. K. M. Flegal, B. K. Kit, H. Orpana, and B. I. Graubard, “Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 309, no. 1, pp. 71–82, 2013. View at Publisher · View at Google Scholar
  55. A. R. Folsom, H. T. Qamhieh, R. R. Wing et al., “Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults,” Arteriosclerosis and Thrombosis, vol. 13, no. 2, pp. 162–169, 1993. View at Google Scholar · View at Scopus
  56. I. Mertens and L. F. Van Gaal, “Obesity, haemostasis and the fibrinolytic system,” Obesity Reviews, vol. 3, no. 2, pp. 85–101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Carpenter and S. Cohen, “Epidermal growth factor,” The Journal of Biological Chemistry, vol. 265, no. 14, pp. 7709–7712, 1990. View at Google Scholar · View at Scopus
  58. M. Grau, C. Rodríguez, M. Soley, and I. Ramírez, “Relationship between epidermal growth factor in mouse submandibular glands, plasma, and bile: effects of catecholamines and fasting,” Endocrinology, vol. 135, no. 5, pp. 1854–1862, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Gogg and U. Smith, “Epidermal growth factor and transforming growth factor α mimic the effects of insulin in human fat cells and augment downstream signaling in insulin resistance,” Journal of Biological Chemistry, vol. 277, no. 39, pp. 36045–36051, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Schlessinger and A. Ullrich, “Growth factor signaling by receptor tyrosine kinases,” Neuron, vol. 9, no. 3, pp. 383–391, 1992. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Kasayama, Y. Ohba, and T. Oka, “Epidermal growth factor deficiency associated with diabetes mellitus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 19, pp. 7644–7648, 1989. View at Google Scholar · View at Scopus
  62. K. J. Strissel, Z. Stancheva, H. Miyoshi et al., “Adipocyte death, adipose tissue remodeling, and obesity complications,” Diabetes, vol. 56, no. 12, pp. 2910–2918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Skurk, C. Alberti-Huber, C. Herder, and H. Hauner, “Relationship between adipocyte size and adipokine expression and secretion,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 1023–1033, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Lelliott and A. J. Vidal-Puig, “Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation,” International Journal of Obesity, vol. 28, no. 4, pp. S22–S28, 2004. View at Publisher · View at Google Scholar · View at Scopus